National burden of the pharmaceutical cost of wet compresses and its cost predictors: nationwide cross-sectional study in Japan

被引:16
作者
Itoh, Hiroaki [1 ]
Saito, Tomoyuki [2 ,3 ]
Nojiri, Shuko [4 ]
Hiratsuka, Yoshimune [5 ]
Yokoyama, Kazuhito [1 ,6 ]
机构
[1] Juntendo Univ, Fac Med, Dept Epidemiol & Environm Hlth, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan
[3] Juntendo Univ Hosp, Dept Pharm, Bunkyo Ku, 3-1-3 Hongo, Tokyo 1138431, Japan
[4] Juntendo Univ, Med Technol Innovat Ctr, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan
[5] Juntendo Univ, Dept Ophthalmol, Fac Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan
[6] Int Univ Hlth & Welf, Dept Epidemiol & Social Med, Grad Sch Publ Hlth, 4-1-26 Akasaka, Minato City, Tokyo 1078402, Japan
基金
日本学术振兴会;
关键词
National database; Health insurance claims; Receipt; Wet compress; Poultice; Cost; OSTEOARTHRITIS;
D O I
10.1186/s13561-019-0238-6
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background: Although a high number of wet compresses are prescribed daily in medical institutions in Japan, our understanding of the national burden of the cost of wet compresses and the details regarding their prescription is far from complete. We investigated the national burden of the annual pharmaceutical cost of wet compresses prescribed in Japan and estimated the predictors of this cost using nationwide health insurance claims data. Methods: We extracted the records on wet compress products from summary table files obtained from the second version of the "NDB Open Data Japan" website and calculated the annual pharmaceutical cost of wet compresses by patients' 5-year age group, sex, and prefecture. We also conducted an ecological study treating each prefecture as an individual unit and multiple linear regression analyses using the age-standardized cost of wet compresses per resident as a dependent variable. Results: The annual pharmaceutical cost of wet compresses prescribed in Japan in fiscal year 2015 was 149.0 billion Japanese yen (1.18 billion euros; 1.33 billion USD). Multiple linear regression analyses showed that the number of orthopedists and rehabilitation physicians per 100,000 residents were significantly positively associated with the annual pharmaceutical cost of wet compresses per resident (P = 0.042 and P = 0.008, respectively). Conclusions: The annual pharmaceutical cost of wet compresses prescribed in Japan has a considerable impact on the nation's limited healthcare resources. The number of orthopedists and rehabilitation physicians per 100,000 residents may be independent predictors of the wet compress cost in Japan.
引用
收藏
页数:7
相关论文
共 34 条
[11]   Long-term clinical benefits and costs of an integrated rehabilitation programme compared with outpatient physiotherapy for chronic knee pain [J].
Jessep, Sally A. ;
Walsh, Nicola E. ;
Ratcliffe, Julie ;
Hurley, Michael V. .
PHYSIOTHERAPY, 2009, 95 (02) :94-102
[12]  
Kaji S, 2017, ASAHI SHIMBUN DIGITA
[13]  
Kawaguchi H, 2016, JPN J JOINT DIS, V35, P1
[14]   Insurer and Out-of-Pocket Costs of Osteoarthritis in the US Evidence From National Survey Data [J].
Kotlarz, Harry ;
Gunnarsson, Candace L. ;
Fang, Hai ;
Rizzo, John A. .
ARTHRITIS AND RHEUMATISM, 2009, 60 (12) :3546-3553
[15]   Financial cost of osteoarthritis in France -: The "COART"' France study [J].
Le Pen, C ;
Reygrobellet, C ;
Gérentes, I .
JOINT BONE SPINE, 2005, 72 (06) :567-570
[16]  
Ministry of Education Culture Sports Science and Technology, 1997, UND NO AR NI KANS CH
[17]  
Ministry of Health Labour and Welfare, 2 NDB OP DAT JAP 201
[18]  
Ministry of Health Labour and Welfare, 2017, COMM 2 NDB OP DAT JA
[19]  
Ministry of Health Labour and Welfare, 2016, APPR PRESCR DRUGS, P375
[20]  
Ministry of Health Labour and Welfare, 2016, 1 NDB OP DAT JAP 201